(Q45357890)

13 December 2017

title

Efficacy and adverse effects of the antiviral compound plerixafor in feline immunodeficiency virus-infected cats (English)

1 reference

feline immunodeficiency virus

13 December 2017

main subject

object named as

feline immunodeficiency virus

1 reference

1

1 reference

13 December 2017

5

J Balzarini

1 reference

13 December 2017

C Stengel

2

1 reference

13 December 2017

D Klein

series ordinal

3

1 reference

13 December 2017

H Egberink

series ordinal

4

1 reference

13 December 2017

language of work or name

1 reference

30 March 2012

1 reference

Journal of Veterinary Internal Medicine

13 December 2017

published in

1 reference

13 December 2017

volume

26

1 reference

13 December 2017

issue

3

1 reference

13 December 2017

page(s)

483-490

1 reference

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Chemokine receptors - the new frontier for AIDS research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Inhibitory effect of newly developed CXC-chemokine receptor 4 antagonists on the infection with feline immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Preferential feline immunodeficiency virus (FIV) infection of CD4+ CD25+ T-regulatory cells correlates both with surface expression of CXCR4 and activation of FIV long terminal repeat binding cellular transcriptional factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Is AZT/3TC therapy effective against FIV infection or immunopathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Phylogenetic analysis of feline immunodeficiency virus in Central Europe: a prerequisite for vaccination and molecular diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: influence of mismatches on quantification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

CXC-chemokine receptor 4 is not a coreceptor for human herpesvirus 7 entry into CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Immunomodulatory activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA), a potent anti-HIV nucleotide analogue, on in vivo murine models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Prevalence of feline calicivirus, feline leukaemia virus and antibodies to FIV in cats with chronic stomatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Antiviral activity of the bicyclam derivative JM3100 against drug-resistant strains of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Zidovudine toxicity to cats infected with feline leukemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Early therapy of feline leukemia virus infection (FeLV-FAIDS) with 9-(2-phosphonylmethoxyethyl)adenine (PMEA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00904.X

10.1111/J.1939-1676.2012.00904.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference